Trial intelligence / Profile preview

Dantrolene for Hyperthermia After Subarachnoidal Hemorrhage

NCT00796900Phase 3Terminated

Sponsor
Medical University of Vienna
Start
May 2008
Primary completion
Mar 2011
Modality
Classical Binding Small Molecules
Countries
1
01

Overview

A Phase 3 trial of dantrolene in hyperthermia, sponsored by Medical University of Vienna. Started May 2008; status: terminated.

02

Drugs

dantrolene
03

Conditions

hyperthermia

Beyond the preview

Go deeper on NCT00796900.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00796900.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call